Immune Microenvironment of Brain Metastases—Are Microglia and Other Brain Macrophages Little Helpers?
Brain metastases are common intracranial neoplasms and their frequency increases with prolonged survival of cancer patients. New pharmaceuticals targeting oncogenic kinases and immune checkpoint inhibitors augment both overall and progression-free survival in patients with brain metastases, but are...
Main Authors: | Hua You, Szymon Baluszek, Bozena Kaminska |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01941/full |
Similar Items
-
Microglia Diversity in Healthy and Diseased Brain: Insights from Single-Cell Omics
by: Natalia Ochocka, et al.
Published: (2021-03-01) -
Oncolytic Virotherapy for Melanoma Brain Metastases, a Potential New Treatment Paradigm?
by: Sauson Soldozy, et al.
Published: (2021-09-01) -
Editorial: Radiotherapy strategies for precise treatment on brain metastases
by: Eric J. Lehrer, et al.
Published: (2024-03-01) -
Editorial: The Role of Modern Neuro-oncology in the Treatment of Primary CNS Tumors, and Brain and Spinal Metastases
by: Marcos Maldaun, et al.
Published: (2020-06-01) -
Case Report: Multiple hemorrhagic metastases to the brain from primary lung choriocarcinoma [version 1; referees: 2 approved]
by: Sunil Munakomi
Published: (2017-05-01)